Payoneer Global Valuation
Is PAYO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PAYO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PAYO's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PAYO's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PAYO?
Key metric: As PAYO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is PAYO's PE Ratio? | |
|---|---|
| PE Ratio | 28.4x |
| Earnings | US$129.99m |
| Market Cap | US$3.68b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.4x |
| Enterprise Value/EBITDA | 19.4x |
| PEG Ratio | 2.9x |
Price to Earnings Ratio vs Peers
How does PAYO's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 63.5x | ||
PAY Paymentus Holdings | 103.2x | 22.9% | US$4.1b |
STNE StoneCo | 8.1x | 14.9% | US$2.9b |
FLYW Flywire | 135.8x | 56.8% | US$2.7b |
PAGS PagSeguro Digital | 6.9x | 10.1% | US$2.4b |
PAYO Payoneer Global | 28.4x | 9.9% | US$3.7b |
Price-To-Earnings vs Peers: PAYO is good value based on its Price-To-Earnings Ratio (28.4x) compared to the peer average (63.5x).
Price to Earnings Ratio vs Industry
How does PAYO's PE Ratio compare vs other companies in the US Diversified Financial Industry?
Price-To-Earnings vs Industry: PAYO is expensive based on its Price-To-Earnings Ratio (28.4x) compared to the US Diversified Financial industry average (17x).
Price to Earnings Ratio vs Fair Ratio
What is PAYO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 28.4x |
| Fair PE Ratio | 16.7x |
Price-To-Earnings vs Fair Ratio: PAYO is expensive based on its Price-To-Earnings Ratio (28.4x) compared to the estimated Fair Price-To-Earnings Ratio (16.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$10.37 | US$12.00 +15.7% | 12.3% | US$14.00 | US$8.50 | n/a | 8 |
| Nov ’25 | US$8.46 | US$9.19 +8.6% | 7.7% | US$10.00 | US$8.00 | n/a | 8 |
| Oct ’25 | US$7.64 | US$8.56 +12.1% | 8.0% | US$10.00 | US$8.00 | n/a | 8 |
| Sep ’25 | US$7.43 | US$8.28 +11.4% | 7.6% | US$9.00 | US$7.00 | n/a | 9 |
| Aug ’25 | US$5.61 | US$7.50 +33.7% | 11.8% | US$9.00 | US$6.50 | n/a | 9 |
| Jul ’25 | US$5.43 | US$7.50 +38.1% | 11.8% | US$9.00 | US$6.50 | n/a | 9 |
| Jun ’25 | US$5.99 | US$7.50 +25.2% | 11.8% | US$9.00 | US$6.50 | n/a | 9 |
| May ’25 | US$4.95 | US$6.67 +34.7% | 14.6% | US$9.00 | US$5.50 | n/a | 9 |
| Apr ’25 | US$4.89 | US$6.61 +35.2% | 15.0% | US$9.00 | US$5.50 | n/a | 9 |
| Mar ’25 | US$4.94 | US$6.89 +39.5% | 15.6% | US$9.00 | US$5.50 | n/a | 9 |
| Feb ’25 | US$4.76 | US$7.56 +58.9% | 14.6% | US$10.00 | US$6.00 | n/a | 8 |
| Jan ’25 | US$5.21 | US$8.00 +53.6% | 12.5% | US$10.00 | US$7.00 | n/a | 8 |
| Dec ’24 | US$5.26 | US$8.22 +56.3% | 11.1% | US$10.00 | US$7.00 | n/a | 9 |
| Nov ’24 | US$5.75 | US$8.61 +49.8% | 12.8% | US$10.00 | US$7.00 | US$8.46 | 9 |
| Oct ’24 | US$6.12 | US$8.72 +42.5% | 11.2% | US$10.00 | US$7.50 | US$7.64 | 9 |
| Sep ’24 | US$6.27 | US$8.50 +35.6% | 13.0% | US$10.00 | US$7.00 | US$7.43 | 9 |
| Aug ’24 | US$5.39 | US$8.17 +51.5% | 14.1% | US$10.00 | US$7.00 | US$5.61 | 9 |
| Jul ’24 | US$4.81 | US$8.44 +75.4% | 12.4% | US$10.00 | US$7.00 | US$5.43 | 8 |
| Jun ’24 | US$4.34 | US$8.44 +94.4% | 12.4% | US$10.00 | US$7.00 | US$5.99 | 8 |
| May ’24 | US$5.37 | US$8.94 +66.4% | 14.4% | US$11.00 | US$7.00 | US$4.95 | 8 |
| Apr ’24 | US$6.28 | US$8.94 +42.3% | 14.4% | US$11.00 | US$7.00 | US$4.89 | 8 |
| Mar ’24 | US$6.60 | US$8.81 +33.5% | 12.7% | US$10.00 | US$7.00 | US$4.94 | 8 |
| Feb ’24 | US$6.12 | US$8.64 +41.2% | 16.0% | US$10.00 | US$6.50 | US$4.76 | 7 |
| Jan ’24 | US$5.47 | US$9.33 +70.6% | 8.0% | US$10.00 | US$8.00 | US$5.21 | 6 |
| Dec ’23 | US$5.40 | US$9.33 +72.8% | 8.0% | US$10.00 | US$8.00 | US$5.26 | 6 |
| Nov ’23 | US$7.80 | US$9.08 +16.5% | 6.7% | US$10.00 | US$8.00 | US$5.75 | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Federal Home Loan Mortgage
US$9.3b
Operates in the secondary mortgage market in the United States.
FMCC
US$3.00
7D
57.1%
1Y
382.3%
Ameriprise Financial
US$54.5b
Provides various financial products and services to individual and institutional clients in the United States and internationally.
AMP
US$562.44
7D
1.9%
1Y
61.7%
Investor
SEK 919.4b
A private equity firm specializing in mature, middle market, buyouts and growth capital investments.
IVSB.F
SEK 26.25
7D
-3.8%
1Y
30.3%